151 related articles for article (PubMed ID: 36952359)
21. Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study.
Guan X; Xu G; Shi A; Zou Y; Zhan Y; Fan Z; Dong Y
Medicine (Baltimore); 2020 Dec; 99(50):e23487. PubMed ID: 33327281
[TBL] [Abstract][Full Text] [Related]
22. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
[TBL] [Abstract][Full Text] [Related]
23. Regional diagnostic rates, treatments, and outcomes among patients with invasive ductal carcinoma.
Moten AS; Lango MN; Goel N; Goldberg AJ
J Surg Res; 2018 Sep; 229():114-121. PubMed ID: 29936977
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
Lim ST; Yu JH; Park HK; Moon BI; Ko BK; Suh YJ
World J Surg Oncol; 2014 Mar; 12():56. PubMed ID: 24621330
[TBL] [Abstract][Full Text] [Related]
25. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
26. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Ruszczyk M; Zirpoli G; Kumar S; Bandera EV; Bovbjerg DH; Jandorf L; Khoury T; Hwang H; Ciupak G; Pawlish K; Schedin P; Masso-Welch P; Ambrosone CB; Hong CC
Cancer Causes Control; 2016 Feb; 27(2):183-98. PubMed ID: 26621543
[TBL] [Abstract][Full Text] [Related]
28. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
29. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
[TBL] [Abstract][Full Text] [Related]
30. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
31. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Prognostic Factors and Construction of Prognostic Models for Invasive Micropapillary Carcinoma of the Breast.
Wang X; Xue Y
Comput Math Methods Med; 2022; 2022():1072218. PubMed ID: 36339683
[TBL] [Abstract][Full Text] [Related]
33. Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Dalenc F; Lusque A; De La Motte Rouge T; Pistilli B; Brain E; Pasquier D; Debled M; Thery JC; Gonçalves A; Desmoulins I; Levy C; Uwer L; Ferrero JM; Eymard JC; Mouret-Reynier MA; Patsouris A; Frenel JS; Petit T; Chevrot M; Bachelot T; Guiu S
Eur J Cancer; 2022 Mar; 164():70-79. PubMed ID: 35176614
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database.
Yang C; Lei C; Zhang Y; Zhang J; Ji F; Pan W; Zhang L; Gao H; Yang M; Li J; Wang K
Front Oncol; 2020; 10():590643. PubMed ID: 33415073
[TBL] [Abstract][Full Text] [Related]
35. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
36. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
Li Y; Zhang N; Zhang H; Yang Q
J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
[TBL] [Abstract][Full Text] [Related]
37. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
[TBL] [Abstract][Full Text] [Related]
39. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
Arps DP; Healy P; Zhao L; Kleer CG; Pang JC
Breast Cancer Res Treat; 2013 Apr; 138(3):719-26. PubMed ID: 23535842
[TBL] [Abstract][Full Text] [Related]
40. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Pestalozzi BC; Zahrieh D; Mallon E; Gusterson BA; Price KN; Gelber RD; Holmberg SB; Lindtner J; Snyder R; Thürlimann B; Murray E; Viale G; Castiglione-Gertsch M; Coates AS; Goldhirsch A;
J Clin Oncol; 2008 Jun; 26(18):3006-14. PubMed ID: 18458044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
